Christopher M Smith Neogenomics Inc (NEO) insider trading activity

Christopher M Smith is Chief Executive Officer of NEOGENOMICS INC. Currently has a direct ownership of 646,302 shares of NEO, which is worth approximately $10.6 Million. The most recent transaction as insider was on Aug 15, 2024, when has been sold 33,130 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 646K

0% 3M change

7.32% 12M change

Total Value Held $10.6 Million

Christopher M Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 15 2024	SELL Payment of exercise price or tax liability	-	33,130 Reduced 4.88%	646,302 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$281,047 $14.86 p/Share	18,913 Reduced 2.91%	631,369 Common Stock
May 11 2024	BUY Exercise of conversion of derivative security	-	96,126 Added 12.39%	679,432 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	-	602,219 Added 50.0%	602,219 Common Stock

Also insider at

AKUS

Akouos, Inc. Healthcare

Director

QDEL

QuidelOrtho Corp Healthcare

Director

CMS